Patents by Inventor Steven T. Lott

Steven T. Lott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11693007
    Abstract: Provided herein are methods of detecting pancreatic cancer, particularly early stage pancreatic cancer, comprising measuring the expression of the biomarker panel TNC-FN III-C, TFPI, and CA19-9. The expression may be determined by an ELISA, such as a multiplex ELISA. Further provided herein are methods of treating subjects identified to have pancreatic cancer.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: July 4, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Ann McNeill Killary, Steven T. Lott, Nanyue Chen, Seetharaman Balasenthil
  • Publication number: 20190376976
    Abstract: Provided herein are methods of detecting pancreatic cancer, particularly early stage pancreatic cancer, comprising 0 measuring the expression of the biomarker panel TNC-FN III-C, TFPI, and CA19-9. The expression may be determined by an ELISA, such as a multiplex ELISA. Further provided herein are methods of treating subjects identified to have pancreatic cancer.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 12, 2019
    Inventors: Ann McNeill KILLARY, Steven T. LOTT, Nanyue CHEN, Seetharaman BALASENTHIL
  • Publication number: 20120058901
    Abstract: Certain aspects of the present invention relate to new diagnostic and prognostic methods involving DEAR1, a gene is located on the short arm of human chromosome 1. Specifically, analysis of expression or structure of this gene for prognosis or recurrence risk assessment is disclosed.
    Type: Application
    Filed: February 12, 2010
    Publication date: March 8, 2012
    Inventors: Ann M. Killary, Steven T. Lott, Bruce G. Haffty